Mechanism and functional role of antibody catalysis.
The light (L) chain of a model antibody (Ab) was deduced to contain a serine protease-like catalytic site capable of cleaving peptide bonds. The catalytic site is encoded by a germline VL gene. The catalytic activity can potentially be improved by somatic sequence diversification and pairing of the L chain with the appropriate heavy chain. Autoimmune disease is associated with increased synthesis of antigen (Ag)-specific Abs, but the reasons for this phenomenon are not known. Only recently has attention turned to the functional role of the catalytic function. Preliminary studies confirm that the catalytic cleavage of peptide bonds is a more potent means to achieve Ag neutralization, compared to reversible Ag binding. Administration of a monoclonal Ab to VIP in experimental animals induces an inflammatory response in the airways, suggesting that catalytic autoantibodies to this peptide found in airway disease and lupus are capable of causing airway dysfunction. The phenomenon of autoantibody catalysis can potentially be applied to isolate efficient catalysts directed against tumor or microbial Ags by exposing the autoimmune repertoire to such Ags or their analogs capable of recruiting the germline VL gene encoding the catalytic site.
Paul
S
S
Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston 77030, USA. paul@casper.med.uth.tms.edu
D000818:Animals; D017151:Antibodies, Catalytic / Q000502:physiology*; D001323:Autoantibodies / Q000502:physiology; D002384:Catalysis; D006801:Humans; D011485:Protein Binding
D017151:Antibodies, Catalytic; D001323:Autoantibodies